URR in Dialysis: Calculation Methods, Purpose, and Impact

The urea reduction ratio, or URR, measures how effectively a single hemodialysis session clears urea from the blood, expressed as the percentage drop in blood urea nitrogen (BUN) from the start to the end of treatment. Clinical guidelines recommend a minimum URR above 65%, with a target above 70% for patients dialyzing three times per week. The calculation itself is straightforward, but getting an accurate number depends on careful blood sampling, and interpreting what URR means for any individual patient involves subtleties that the simple percentage can obscure.

What URR Measures and Why Urea Is the Marker

URR is calculated by comparing two blood draws: one taken just before a dialysis session begins, and one taken just after it ends. The formula is simply the predialysis BUN minus the postdialysis BUN, divided by the predialysis BUN, then multiplied by 100 to get a percentage. If your BUN was 80 mg/dL before dialysis and 20 mg/dL afterward, your URR is 75%. That tells the care team that the session removed three-quarters of the urea circulating in your blood.

Urea became the standard marker molecule for dialysis adequacy because it connects directly to dietary protein intake, and its generation in the body correlates well with the buildup of other waste products that healthy kidneys would normally clear.¹ It is small, distributes evenly through body water, and is easy to measure with a routine blood test. No single molecule perfectly represents every toxin that accumulates in kidney failure, but urea serves as a practical stand-in. When urea clearance is adequate, clearance of many other small waste molecules tends to be adequate too.

How URR Links to Survival

The landmark study that cemented URR as a clinical tool analyzed over 13,000 hemodialysis patients in the early 1990s. Patients whose URR fell below 60% had a meaningfully higher risk of death: the odds ratio was 1.28 for those with a URR between 55% and 59%, and 1.39 for those below 55%, compared with patients achieving 65% to 69%.² That same study found that more than half of patients at the time had URR values below 60%, meaning the majority were receiving what we would now consider inadequate dialysis. Serum albumin, a marker of nutritional status, turned out to be an even stronger predictor of death than URR, which underscores that dialysis dose alone does not determine outcomes.

More recent data confirm the relationship between higher URR and lower mortality at the facility level. An analysis of U.S. dialysis centers found that facilities in the lowest quintile of guideline compliance for URR had 22% higher mortality rates than those in the highest quintile. For every 10-percentage-point increase in the fraction of a facility’s patients meeting the 65% URR threshold, mortality dropped by about 2.2%.³ These numbers describe trends across large populations; an individual patient’s risk depends on many other factors, including nutritional status, cardiovascular health, and how well they tolerate treatment.

Getting an Accurate Number Depends on How You Draw the Blood

URR looks like a simple before-and-after measurement, but the postdialysis blood draw is surprisingly tricky. Two problems can throw it off in opposite directions. If the sample is taken from the dialysis access line immediately after stopping the blood pump, recirculated blood that has already passed through the dialyzer can mix into the sample, making the postdialysis BUN appear artificially low and the URR artificially high.⁴ Conversely, if you wait too long after dialysis ends, urea that was trapped in tissues during treatment seeps back into the bloodstream, a phenomenon called urea rebound, and the postdialysis BUN rises, making URR look lower than the session actually achieved.

Research into this problem has shown that most cases of extreme urea rebound turn out to be caused by access recirculation rather than tissue rebound when the postdialysis sample is drawn without a slow-flow period. In one study, rebound measured with a full-flow sample was substantial, but when blood was drawn after a 15-second slow-flow period, rebound dropped to levels consistent with predicted tissue rebound alone. Eight of the 16 patients studied had access recirculation above 15%, and the degree of recirculation strongly correlated with the apparent rebound.⁵ The practical takeaway is that guidelines recommend slowing or briefly stopping the blood pump and then drawing from the arterial line to get a sample that reflects the patient’s actual systemic BUN, not dialyzer-influenced blood.

Access recirculation can also distort the mathematical models used alongside URR. A mathematical analysis showed that when recirculation is present throughout a session, the modeled urea distribution volume is typically underestimated when URR is at or below 70%, but may appear unchanged when URR exceeds 70%, masking even severe recirculation.⁶ This means a patient with a high URR and significant access recirculation might look fine on paper while actually receiving compromised treatment. Inconsistencies in sampling methods remain a real-world problem; a survey of pediatric dialysis centers in England found that four of ten units were not following the recommended postdialysis sampling technique.⁷

Where URR Falls Short Compared to Kt/V

URR’s greatest strength, its simplicity, is also its main weakness. It captures only the percentage drop in BUN and ignores several factors that affect how much urea was actually removed from the body. The most important of these are ultrafiltration (the fluid removed during dialysis), the patient’s body size, session length, and any urea generated during the session itself. Kt/V, the other widely used adequacy metric, accounts for these variables by modeling the volume of blood cleared of urea relative to the patient’s total body water.

A detailed mathematical analysis found that URR and Kt/V can diverge in clinically meaningful ways. A patient can have a URR below 65%, suggesting inadequate dialysis, while their Kt/V exceeds the 1.2 target. This happens most often in patients who still have some residual kidney function. When renal urea clearance was greater than 1.0 mL/min, URR could be below 65% even when Kt/V reached 2.0 or higher, because the kidneys’ continuous clearance between sessions lowers the predialysis BUN, compressing the ratio without reflecting poor dialysis.⁸ The reverse also occurred: URR could exceed 65% while Kt/V fell below 1.2, though this was limited to patients with minimal residual kidney function.

Ultrafiltration adds another complication. When a large volume of fluid is removed during dialysis, the body’s urea distribution volume contracts, concentrating urea in a smaller space before the dialyzer clears it. This convective removal effectively adds to urea clearance, but URR doesn’t capture it. On the other hand, aggressive fluid removal may paradoxically enhance urea rebound after treatment ends, because reduced blood volume can trap urea in peripheral tissues during the session, which then re-equilibrates afterward.⁹

Researchers have proposed modified URR formulas that correct for ultrafiltration volume and the urea generated during a session. One such equation was validated against 145 treatments in 33 patients and predicted the Kt/V value much more tightly than standard URR, with a narrow range of Kt/V at any given modified URR value across a wide range of fluid removal and session lengths.¹⁰ Despite this improvement, modified URR formulas have not replaced standard URR in routine clinical use, partly because facilities already set up for Kt/V calculations have little incentive to adopt a middle-ground formula.

What Moves URR Up or Down in Practice

For patients and clinicians trying to improve a below-target URR, the main levers are blood flow rate, dialysate flow rate, and session length. Each one works through a slightly different mechanism, and they interact with each other.

Raising the blood flow rate pushes more blood through the dialyzer per minute, increasing the amount of urea delivered to the membrane for removal. A prospective study of 63 patients whose blood flow was increased by 100 mL/min (from a median of 252 to 349 mL/min) found a significant positive association between the flow increase and the achieved URR.¹¹ A separate study comparing blood flows of 200 mL/min versus 250 mL/min found that the share of patients meeting the URR target of 65% more than doubled, from about 17% to 36%, with the higher flow.¹² Higher blood flows are not always tolerated well, particularly in patients with cardiovascular instability or older vascular access, so the decision involves balancing adequacy against comfort and safety.

Dialysate flow rate also matters. A systematic review and meta-analysis found that increasing dialysate flow from 500 mL/min to 800 mL/min raised URR by about 3.4 percentage points on average.¹³ That might sound modest, but for a patient sitting at 63% or 64%, a few points can be the difference between meeting and missing the guideline threshold. Higher dialysate flows do consume more dialysate, which increases supply costs, and the benefit plateaus once the dialysate-to-blood flow ratio gets high enough that the membrane becomes the bottleneck.

Session length is perhaps the most intuitive factor: more time on dialysis means more passes of blood through the dialyzer and more total urea removed. But extending sessions is often the hardest sell for patients, who already spend several hours connected to a machine three or more times a week. In practice, clinicians usually optimize flow rates first and extend session time when those adjustments are not enough.

URR in Children

Pediatric hemodialysis presents a specific challenge for URR. Children have smaller blood volumes relative to the extracorporeal circuit volume, faster metabolic rates, and different body-water distribution compared with adults. These factors make URR more sensitive to sampling errors and less reflective of actual clearance.

The English pediatric dialysis survey mentioned earlier found a stark discrepancy between the two adequacy measures: using URR, up to 44% of children appeared to be receiving inadequate dialysis, but when the same sessions were evaluated by Kt/V, no more than 6% fell below the adequacy threshold.⁷ That gap is enormous and has practical consequences: basing decisions on URR alone could lead to unnecessarily aggressive dialysis prescriptions in children who are actually receiving adequate treatment. Suboptimal dialysis may also occur when the dose is overestimated by models that fail to account for compartment effects and post-treatment urea rebound, a concern that is heightened in smaller patients.¹⁴ For these reasons, most pediatric nephrology guidelines lean toward Kt/V rather than URR as the primary adequacy metric.

Residual Kidney Function Changes What URR Means

Many patients starting hemodialysis still have some remaining kidney function, even if it is not enough to keep them off dialysis. This residual kidney function (RKF) continuously clears urea between sessions, keeping the predialysis BUN lower than it would be in someone with no kidney function at all. Because URR is a ratio based on the predialysis value, a lower starting point compresses the ratio even when the absolute amount of urea removed during the session is the same or higher. The result is that URR can understate the total clearance a patient is actually receiving.

A study of hemodialysis patients found that the survival benefit of higher URR (or its kinetic equivalent, Kt/V) was concentrated among patients with low residual kidney function, defined as renal urea clearance below 3.0 mL/min. Among patients with substantial remaining kidney function, the association between higher dialysis dose and better survival was much weaker.¹⁵ This makes intuitive sense: the kidneys’ continuous clearance provides a baseline of waste removal that dialysis tops up. When that baseline is substantial, modest differences in the dialysis session’s URR matter less.

Quantifying how much credit to give residual function is not straightforward. Renal urea clearance underestimates the true glomerular filtration rate because urea is reabsorbed in the kidney tubules, while dialyzer urea clearance overestimates the clearance of other waste molecules because urea diffuses faster than most toxins. Taking both of these into account, the kidneys are roughly twice as effective at clearing a range of waste products compared with dialysis delivering the same urea clearance.¹⁶ This has led to growing interest in incremental dialysis, where patients with meaningful RKF start with fewer or shorter sessions and increase the prescription only as their native kidney function declines. In that approach, URR from any single session is less informative than a combined measure of dialysis plus renal clearance.

Nutritional Information Hidden in URR

Because urea comes from protein breakdown, the predialysis BUN indirectly reflects how much protein a patient is eating or catabolizing. This connection is formalized in the normalized protein catabolic rate, or nPCR, which can be calculated from the same predialysis and postdialysis BUN values used for URR.¹⁷ In a patient who is in nitrogen balance, nPCR gives a reasonable estimate of dietary protein intake.

This creates a paradox that confuses patients and sometimes clinicians. A patient who eats very little protein generates less urea, so their predialysis BUN is low. The same dialysis session then produces a higher URR because the denominator is smaller. The patient appears to be well-dialyzed, but the underlying problem is malnutrition, not excellent clearance. The 1993 study that first tied URR to mortality also found that serum albumin, the classic marker of protein status, was 21 times more powerful than URR as a predictor of death.² A high URR combined with a low albumin is a red flag that the number is being driven by poor intake rather than effective dialysis. This is why adequacy assessments in well-run units look at URR, albumin, nPCR, and clinical symptoms together rather than relying on any single number.

URR as a Pay-for-Performance Metric

In the United States, the Centers for Medicare and Medicaid Services designated URR as a pay-for-performance measure for dialysis facilities. The rationale was to incentivize clinics to deliver adequate treatment, but questions have been raised about how well the metric actually captures facility quality. Some portion of a patient’s URR is driven by factors outside the clinic’s control: body size, protein intake, treatment adherence (patients who leave sessions early or miss treatments entirely), and residual kidney function all affect the number.¹⁸ A facility caring for a population with high rates of treatment non-adherence might report lower average URR even if its dialysis machines and prescriptions are perfectly appropriate. Conversely, a clinic whose patients happen to eat less protein might look excellent on URR without delivering genuinely superior care. Despite these limitations, URR remains a core quality indicator because it is simple to calculate, easy to audit, and does broadly track with outcomes at the population level.

Real-Time Monitoring With Ionic Dialysance

Modern dialysis machines can estimate clearance in real time using ionic dialysance, which measures how effectively the dialyzer removes electrolytes from the blood by tracking conductivity changes in the dialysate. Because electrolyte clearance through the dialyzer membrane correlates closely with urea clearance, the machine can estimate Kt/V and, by extension, URR without any blood draws at all.

Validation studies have found strong correlations between ionic dialysance measurements and traditional urea-based values. One study reported that Kt/V measured by ionic dialysance underestimated the urea-based value by a mean of only 1.5%.¹⁹ A more recent study similarly found a strong correlation between ionic-dialysance-derived URR and measured URR, though the authors noted that ionic dialysance still shares some of URR’s inherent limitations as an adequacy indicator, particularly its insensitivity to ultrafiltration and urea generation.²⁰

The appeal of ionic dialysance is that it provides a reading for every session, not just the monthly or quarterly sessions when blood is sampled. This continuous monitoring can catch problems like clotted dialyzer fibers, access flow issues, or inadvertently shortened treatments that would not show up until the next scheduled lab draw. It does not replace periodic blood-based URR or Kt/V measurements, but it fills in the gaps between them, giving clinicians a much more complete picture of treatment consistency over time.

Why a Ten-Year Follow-Up Found URR and Kt/V Equally Predictive

A lingering debate in nephrology has been whether the more complex Kt/V model provides genuinely better prognostic information than the simpler URR. A large Taiwanese cohort study with ten years of follow-up found that URR and Kt/V had essentially equivalent predictive value for all-cause mortality, with the KDOQI guideline recommending a minimum URR above 65% and a target above 70% for thrice-weekly treatments under five hours.²¹ At first glance, this seems to undercut the argument for using the more complicated measure. But the finding really means that at the population level, both metrics sort patients into roughly the same risk categories. Where Kt/V earns its keep is in the individual cases where the two diverge, particularly in patients with significant residual kidney function, high ultrafiltration volumes, or unusual body composition. For quality reporting and population surveillance, URR works just fine. For fine-tuning a specific patient’s prescription, Kt/V or a modified URR still provides more information.